Literature DB >> 33400885

The regulation of liver cytochrome P450 expression and activity by the brain serotonergic system in different experimental models.

Ewa Bromek1, Władysława Anna Daniel1.   

Abstract

Introduction: Cytochrome P450 (CYP) metabolizes vital endogenous (steroids, vitamins) and exogenous (drugs, toxins) substrates. Studies of the last decade have revealed that the brain dopaminergic and noradrenergic systems are involved in the regulation of CYP. Recent research indicates that the brain serotonergic system is also engaged in its regulation.Areas covered: This review focuses on the role of the brain serotonergic system in the regulation of liver CYP expression. It shows the effect of lesion and activation of the serotonergic system after peripheral or intracerebral injections of neurotoxins, serotonin precursor, or serotonin (5-HT) receptor agonists. An opposite role of the hypothalamic paraventricular and arcuate nuclei and 5-HT receptors present therein in the regulation of CYP is described. The engagement of those nuclei in the neuroendocrine regulation of CYP by hypothalamic releasing or inhibiting hormones, pituitary hormones, and peripheral gland hormones are shown.Expert opinion: In general, the brain serotonergic system negatively regulates liver cytochrome P450. However, the effects of serotonergic agents on the enzyme expression depend on their mechanism of action, the route of administration (intracerebral/peripheral), as well as on local intracerebral site of injection and 5-HT receptor-subtypes present therein.

Entities:  

Keywords:  Brain; cytochrome P450 regulation; hormones; liver; serotonergic receptors; serotonin

Year:  2021        PMID: 33400885     DOI: 10.1080/17425255.2021.1872543

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  2 in total

1.  The impact of noradrenergic neurotoxin DSP-4 and noradrenaline transporter knockout (NET-KO) on the activity of liver cytochrome P450 3A (CYP3A) in male and female mice.

Authors:  Ewa Bromek; Przemysław Jan Danek; Jacek Wójcikowski; Agnieszka Basińska-Ziobroń; Renata Pukło; Joanna Solich; Marta Dziedzicka-Wasylewska; Władysława Anna Daniel
Journal:  Pharmacol Rep       Date:  2022-08-26       Impact factor: 3.919

2.  The Influence of Long-Term Treatment with Asenapine on Liver Cytochrome P450 Expression and Activity in the Rat. The Involvement of Different Mechanisms.

Authors:  Przemysław J Danek; Ewa Bromek; Władysława A Daniel
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.